Page 3 - Robertl Gershon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robertl gershon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robertl Gershon Today - Breaking & Trending Today

Mauna Kea Technologies Receives U.S. FDA 510(k) Clearance of its Next-Generation Cellvizio Platform Combined with a Fluorescent Contrast Agent

Mauna Kea Technologies Receives U.S. FDA 510(k) Clearance of its Next-Generation Cellvizio Platform Combined with a Fluorescent Contrast Agent
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , France General , Robertl Gershon , Thomas Grojean , Mike Piccinino , French Financial Markets Authority Autorit , American Foregut Society , Drug Administration , Kea Technologies , Confocal Miniprobes , Mauna Kea , Chief Executive Officer , Mauna Kea Technologies , Universal Registration Document , French Financial Markets Authority , Cap Investor Relations ,

Mauna Kea Technologies Reports Second Quarter and First Half of 2021 Sales

Mauna Kea Technologies Reports Second Quarter and First Half of 2021 Sales
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Robertl Gershon , Thomas Grojean , Mike Piccinino , French Financial Markets Authority Autorit , Regulatory News , Kea Technologies , Chief Executive Officer , Mauna Kea Technologies , First Half , Systems Sold , System Placements , Cellvizio System , Financial Results Announcement , Universal Registration Document , French Financial Markets Authority , Cap Investor Relations , ஒன்றுபட்டது மாநிலங்களில் , ஒழுங்குமுறை செய்தி , கீ தொழில்நுட்பங்கள் , தலைமை நிர்வாகி அதிகாரி , ம Una னா கீ தொழில்நுட்பங்கள் , முதல் பாதி , அமைப்புகள் விற்கப்பட்டது , அமைப்பு வேலைவாய்ப்புகள் , நிதி முடிவுகள் அறிவிப்பு ,

Mauna Kea Technologies Announces Completion of Enrollment of the First in Human Clinical Study Combining Robotic-Assisted Bronchoscopy and Needle-Based Confocal Laser Endomicroscopy

Mauna Kea Technologies Announces Completion of Enrollment of the First in Human Clinical Study Combining Robotic-Assisted Bronchoscopy and Needle-Based Confocal Laser Endomicroscopy
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , France General , Fox Chase , Noord Holland , Christopher Manley , Robertl Gershon , Thomas Grojean , Mike Piccinino , Jouket Annema , French Financial Markets Authority Autorit , Amsterdam University Medical Center , Auris Health Inc , Lung Cancer Initiative , Johnson Medical Devices Companies , Monarch Platform , Auris Health , Kea Technologies , Interventional Pulmonology , Assistant Professor , Fox Chase Cancer Center , Pulmonary Endoscopy , Mauna Kea Technologies , Chief Executive Officer , Mauna Kea , Universal Registration Document , French Financial Markets Authority ,

Mauna Kea Technologies Announces 7 Presentations Highlighting the Clinical Value of Cellvizio in Gastrointestinal Diseases at Digestive Disease Week (DDW) 2021 Virtual

Mauna Kea Technologies Announces 7 Presentations Highlighting the Clinical Value of Cellvizio in Gastrointestinal Diseases at Digestive Disease Week (DDW) 2021 Virtual
Regulatory News:
Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced the presentation of 7 abstracts supporting Cellvizio at Digestive Disease Week (DDW) 2021 Virtual, being held May 21-23. These abstracts focus on Barrett s esophagus (BE), inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) and associated food allergies, pancreatic cysts and other gastrointestinal diseases. Studies are focused on how the use of Cellvizio potentially impacts patient management and improves outcomes. ....

United States , United Kingdom , Eau Claire , Red Hill , North Somerset , Ralf Kiesslich , Robertl Gershon , Marietta Iacucci , Miguel Puga Tejada , Nastazja Dagny Pilonis , Thomas Grojean , Enfermedades Digestiva , Mike Piccinino , Horst Schmidt Kliniken Wiesbaden , Jorge Machicado , Gastroenterol Hepatol , Mathew Vithayathil , Karen Chang , University Hospitals , American Society For Gastrointestinal Endoscopy , French Financial Markets Authority Autorit , Institute Of Oncology , University Of Birmingham , Institute Of Immunology , University Of California System , University Of Cambridge ,

Mauna Kea Technologies Announces it has Signed its 15th Hospital in Europe for Irritable Bowel Syndrome (IBS) Food Allergy Application

Confirming the Role and added value of Cellvizio for the Identification and Management of IBS Patients with Atypical Food Allergies Regulatory News: Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) ....

United States , Christian Sina , Robertl Gershon , Thomas Grojean , Mauna Kea , Annette Fritscher , Mike Piccinino , Jerome Foundation , French Financial Markets Authority Autorit , University Hospital Schleswig Holstein , Atypical Food Allergies , Kea Technologies , Irritable Bowel Syndrome , Hexagon Sant , Annette Fritscher Ravens , Experimental Endoscopy Unit , Gastroenterologist Director , Fresenius Kabi Professor , Chief Executive Officer , Mauna Kea Technologies , Universal Registration Document , French Financial Markets Authority , Gastroenterology Task Force , Cap Investor Relations , ஒன்றுபட்டது மாநிலங்களில் , கிறிஸ்துவர் சினா ,